Global Pediatric Drugs and Vaccines market is expected to grow from US$ 120080 million in 2025 to US$ 205620 million in 2031; it is expected to grow at a CAGR of 9.4% from 2025 to 2031.

Global Pediatric Drugs and Vaccines Market Size and Outlook 2025-31

The global Pediatric Drugs and Vaccines market size is predicted to grow from US$ 120080 million in 2025 to US$ 205620 million in 2031; it is expected to grow at a CAGR of 9.4% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a childs age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Pediatric Drugs and Vaccines Industry Forecast looks at past sales and reviews total world Pediatric Drugs and Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Pediatric Drugs and Vaccines sales for 2025 through 2031. With Pediatric Drugs and Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pediatric Drugs and Vaccines industry. This Insight Report provides a comprehensive analysis of the global Pediatric Drugs and Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pediatric Drugs and Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Pediatric Drugs and Vaccines market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pediatric Drugs and Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pediatric Drugs and Vaccines. This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Drugs and Vaccines market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Diphtheria &nbsp;&nbsp;&nbsp; Influenza &nbsp;&nbsp;&nbsp; Hepatitis &nbsp;&nbsp;&nbsp; Pneumococcal Diseases &nbsp;&nbsp;&nbsp; Meningococcal Diseases &nbsp;&nbsp;&nbsp; Mumps &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Newborn &nbsp;&nbsp;&nbsp; Infant &nbsp;&nbsp;&nbsp; Child This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Merck & Co., Inc. (USA) &nbsp;&nbsp;&nbsp; Abbott Laboratories (USA) &nbsp;&nbsp;&nbsp; Amgen, Inc. (USA) &nbsp;&nbsp;&nbsp; Eli Lilly and Company (USA) &nbsp;&nbsp;&nbsp; F. Hoffmann-La Roche Ltd (Switzerland) &nbsp;&nbsp;&nbsp; Genentech, Inc. (USA) &nbsp;&nbsp;&nbsp; GlaxoSmithKline plc. (UK) &nbsp;&nbsp;&nbsp; Janssen Biologics B.V. (USA) &nbsp;&nbsp;&nbsp; Actelion Pharmaceuticals &nbsp;&nbsp;&nbsp; AstraZeneca Plc. (UK) &nbsp;&nbsp;&nbsp; Boehringer Ingelheim GmbH (Germany) &nbsp;&nbsp;&nbsp; Bristol-Myers Squibb Company (USA) &nbsp;&nbsp;&nbsp; Allergan, Inc. (USA) &nbsp;&nbsp;&nbsp; Novartis AG (Switzerland) &nbsp;&nbsp;&nbsp; Novo Nordisk A/S (Denmark) &nbsp;&nbsp;&nbsp; Pfizer, Inc. (USA) &nbsp;&nbsp;&nbsp; Sanofi S.A (France) &nbsp;&nbsp;&nbsp; Shionogi Inc. (USA) &nbsp;&nbsp;&nbsp; Takeda Key Questions Addressed in this Report What is the 10-year outlook for the global Pediatric Drugs and Vaccines market? What factors are driving Pediatric Drugs and Vaccines market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Pediatric Drugs and Vaccines market opportunities vary by end market size? How does Pediatric Drugs and Vaccines break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Pediatric Drugs and Vaccines Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Pediatric Drugs and Vaccines by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Pediatric Drugs and Vaccines Segment by Type &nbsp;2.2.1 Diphtheria &nbsp;2.2.2 Influenza &nbsp;2.2.3 Hepatitis &nbsp;2.2.4 Pneumococcal Diseases &nbsp;2.2.5 Meningococcal Diseases &nbsp;2.2.6 Mumps &nbsp;2.2.7 Others &nbsp;2.3 Pediatric Drugs and Vaccines Sales by Type &nbsp;2.3.1 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Pediatric Drugs and Vaccines Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Pediatric Drugs and Vaccines Sale Price by Type (2020-2025) &nbsp;2.4 Pediatric Drugs and Vaccines Segment by Application &nbsp;2.4.1 Newborn &nbsp;2.4.2 Infant &nbsp;2.4.3 Child &nbsp;2.5 Pediatric Drugs and Vaccines Sales by Application &nbsp;2.5.1 Global Pediatric Drugs and Vaccines Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Pediatric Drugs and Vaccines Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Pediatric Drugs and Vaccines Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Pediatric Drugs and Vaccines Breakdown Data by Company &nbsp;3.1.1 Global Pediatric Drugs and Vaccines Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Pediatric Drugs and Vaccines Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Pediatric Drugs and Vaccines Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Pediatric Drugs and Vaccines Revenue by Company (2020-2025) &nbsp;3.2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Pediatric Drugs and Vaccines Sale Price by Company &nbsp;3.4 Key Manufacturers Pediatric Drugs and Vaccines Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Pediatric Drugs and Vaccines Product Location Distribution &nbsp;3.4.2 Players Pediatric Drugs and Vaccines Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Pediatric Drugs and Vaccines by Geographic Region &nbsp;4.1 World Historic Pediatric Drugs and Vaccines Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Pediatric Drugs and Vaccines Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Pediatric Drugs and Vaccines Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Pediatric Drugs and Vaccines Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Pediatric Drugs and Vaccines Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Pediatric Drugs and Vaccines Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Pediatric Drugs and Vaccines Sales Growth &nbsp;4.4 APAC Pediatric Drugs and Vaccines Sales Growth &nbsp;4.5 Europe Pediatric Drugs and Vaccines Sales Growth &nbsp;4.6 Middle East & Africa Pediatric Drugs and Vaccines Sales Growth 5 Americas &nbsp;5.1 Americas Pediatric Drugs and Vaccines Sales by Country &nbsp;5.1.1 Americas Pediatric Drugs and Vaccines Sales by Country (2020-2025) &nbsp;5.1.2 Americas Pediatric Drugs and Vaccines Revenue by Country (2020-2025) &nbsp;5.2 Americas Pediatric Drugs and Vaccines Sales by Type (2020-2025) &nbsp;5.3 Americas Pediatric Drugs and Vaccines Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Pediatric Drugs and Vaccines Sales by Region &nbsp;6.1.1 APAC Pediatric Drugs and Vaccines Sales by Region (2020-2025) &nbsp;6.1.2 APAC Pediatric Drugs and Vaccines Revenue by Region (2020-2025) &nbsp;6.2 APAC Pediatric Drugs and Vaccines Sales by Type (2020-2025) &nbsp;6.3 APAC Pediatric Drugs and Vaccines Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Pediatric Drugs and Vaccines by Country &nbsp;7.1.1 Europe Pediatric Drugs and Vaccines Sales by Country (2020-2025) &nbsp;7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Country (2020-2025) &nbsp;7.2 Europe Pediatric Drugs and Vaccines Sales by Type (2020-2025) &nbsp;7.3 Europe Pediatric Drugs and Vaccines Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Pediatric Drugs and Vaccines by Country &nbsp;8.1.1 Middle East & Africa Pediatric Drugs and Vaccines Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Pediatric Drugs and Vaccines Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Pediatric Drugs and Vaccines Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Pediatric Drugs and Vaccines &nbsp;10.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines &nbsp;10.4 Industry Chain Structure of Pediatric Drugs and Vaccines 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Pediatric Drugs and Vaccines Distributors &nbsp;11.3 Pediatric Drugs and Vaccines Customer 12 World Forecast Review for Pediatric Drugs and Vaccines by Geographic Region &nbsp;12.1 Global Pediatric Drugs and Vaccines Market Size Forecast by Region &nbsp;12.1.1 Global Pediatric Drugs and Vaccines Forecast by Region (2026-2031) &nbsp;12.1.2 Global Pediatric Drugs and Vaccines Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Pediatric Drugs and Vaccines Forecast by Type (2026-2031) &nbsp;12.7 Global Pediatric Drugs and Vaccines Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Merck & Co., Inc. (USA) &nbsp;13.1.1 Merck & Co., Inc. (USA) Company Information &nbsp;13.1.2 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Merck & Co., Inc. (USA) Main Business Overview &nbsp;13.1.5 Merck & Co., Inc. (USA) Latest Developments &nbsp;13.2 Abbott Laboratories (USA) &nbsp;13.2.1 Abbott Laboratories (USA) Company Information &nbsp;13.2.2 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Abbott Laboratories (USA) Main Business Overview &nbsp;13.2.5 Abbott Laboratories (USA) Latest Developments &nbsp;13.3 Amgen, Inc. (USA) &nbsp;13.3.1 Amgen, Inc. (USA) Company Information &nbsp;13.3.2 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Amgen, Inc. (USA) Main Business Overview &nbsp;13.3.5 Amgen, Inc. (USA) Latest Developments &nbsp;13.4 Eli Lilly and Company (USA) &nbsp;13.4.1 Eli Lilly and Company (USA) Company Information &nbsp;13.4.2 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Eli Lilly and Company (USA) Main Business Overview &nbsp;13.4.5 Eli Lilly and Company (USA) Latest Developments &nbsp;13.5 F. Hoffmann-La Roche Ltd (Switzerland) &nbsp;13.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Information &nbsp;13.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Main Business Overview &nbsp;13.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Latest Developments &nbsp;13.6 Genentech, Inc. (USA) &nbsp;13.6.1 Genentech, Inc. (USA) Company Information &nbsp;13.6.2 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Genentech, Inc. (USA) Main Business Overview &nbsp;13.6.5 Genentech, Inc. (USA) Latest Developments &nbsp;13.7 GlaxoSmithKline plc. (UK) &nbsp;13.7.1 GlaxoSmithKline plc. (UK) Company Information &nbsp;13.7.2 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 GlaxoSmithKline plc. (UK) Main Business Overview &nbsp;13.7.5 GlaxoSmithKline plc. (UK) Latest Developments &nbsp;13.8 Janssen Biologics B.V. (USA) &nbsp;13.8.1 Janssen Biologics B.V. (USA) Company Information &nbsp;13.8.2 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Janssen Biologics B.V. (USA) Main Business Overview &nbsp;13.8.5 Janssen Biologics B.V. (USA) Latest Developments &nbsp;13.9 Actelion Pharmaceuticals &nbsp;13.9.1 Actelion Pharmaceuticals Company Information &nbsp;13.9.2 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Actelion Pharmaceuticals Main Business Overview &nbsp;13.9.5 Actelion Pharmaceuticals Latest Developments &nbsp;13.10 AstraZeneca Plc. (UK) &nbsp;13.10.1 AstraZeneca Plc. (UK) Company Information &nbsp;13.10.2 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 AstraZeneca Plc. (UK) Main Business Overview &nbsp;13.10.5 AstraZeneca Plc. (UK) Latest Developments &nbsp;13.11 Boehringer Ingelheim GmbH (Germany) &nbsp;13.11.1 Boehringer Ingelheim GmbH (Germany) Company Information &nbsp;13.11.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Boehringer Ingelheim GmbH (Germany) Main Business Overview &nbsp;13.11.5 Boehringer Ingelheim GmbH (Germany) Latest Developments &nbsp;13.12 Bristol-Myers Squibb Company (USA) &nbsp;13.12.1 Bristol-Myers Squibb Company (USA) Company Information &nbsp;13.12.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Bristol-Myers Squibb Company (USA) Main Business Overview &nbsp;13.12.5 Bristol-Myers Squibb Company (USA) Latest Developments &nbsp;13.13 Allergan, Inc. (USA) &nbsp;13.13.1 Allergan, Inc. (USA) Company Information &nbsp;13.13.2 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.13.4 Allergan, Inc. (USA) Main Business Overview &nbsp;13.13.5 Allergan, Inc. (USA) Latest Developments &nbsp;13.14 Novartis AG (Switzerland) &nbsp;13.14.1 Novartis AG (Switzerland) Company Information &nbsp;13.14.2 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.14.4 Novartis AG (Switzerland) Main Business Overview &nbsp;13.14.5 Novartis AG (Switzerland) Latest Developments &nbsp;13.15 Novo Nordisk A/S (Denmark) &nbsp;13.15.1 Novo Nordisk A/S (Denmark) Company Information &nbsp;13.15.2 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.15.4 Novo Nordisk A/S (Denmark) Main Business Overview &nbsp;13.15.5 Novo Nordisk A/S (Denmark) Latest Developments &nbsp;13.16 Pfizer, Inc. (USA) &nbsp;13.16.1 Pfizer, Inc. (USA) Company Information &nbsp;13.16.2 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.16.4 Pfizer, Inc. (USA) Main Business Overview &nbsp;13.16.5 Pfizer, Inc. (USA) Latest Developments &nbsp;13.17 Sanofi S.A (France) &nbsp;13.17.1 Sanofi S.A (France) Company Information &nbsp;13.17.2 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.17.4 Sanofi S.A (France) Main Business Overview &nbsp;13.17.5 Sanofi S.A (France) Latest Developments &nbsp;13.18 Shionogi Inc. (USA) &nbsp;13.18.1 Shionogi Inc. (USA) Company Information &nbsp;13.18.2 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.18.4 Shionogi Inc. (USA) Main Business Overview &nbsp;13.18.5 Shionogi Inc. (USA) Latest Developments &nbsp;13.19 Takeda &nbsp;13.19.1 Takeda Company Information &nbsp;13.19.2 Takeda Pediatric Drugs and Vaccines Product Portfolios and Specifications &nbsp;13.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.19.4 Takeda Main Business Overview &nbsp;13.19.5 Takeda Latest Developments 14 Research Findings and Conclusion

Report	Global Pediatric Drugs and Vaccines Market Growth 2025-2031
Selected License	Multi ID: LPI24807

Buyer Information

Order Summary